# Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

> **NCT04099238** · — · COMPLETED · sponsor: **Bayer** · enrollment: 3739 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Oral anticoagulant

## Key facts

- **NCT ID:** NCT04099238
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2020-07-16
- **Final completion:** 2020-07-16
- **Target enrollment:** 3739 (ACTUAL)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04099238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04099238, "Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04099238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*